United States Pharmacovigilence Retapamulin-Prescribing

NCT01153880 · clinicaltrials.gov ↗

COMPLETED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Infections, Bacterial

Interventions

DRUG: Retapamulin
DRUG: Co-prescription of retapamulin and topical mupirocin

Sponsor

GlaxoSmithKline